Genomic Screening of the General Adult Population: Key Concepts for Assessing Net Benefit with Systematic Evidence Reviews
暂无分享,去创建一个
G. Henderson | J. Berg | D. Jonas | A. Prince | J. Evans
[1] Heidi L Rehm,et al. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. , 2014, American journal of human genetics.
[2] S. Fullerton,et al. Returning pleiotropic results from genetic testing to patients and research participants. , 2014, JAMA.
[3] Robert C. Green,et al. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium , 2013, Genetics in Medicine.
[4] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[5] A. Olshan,et al. We screen newborns, don’t we?: realizing the promise of public health genomics , 2013, Genetics in Medicine.
[6] E. Warner,et al. Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer. , 2011, Breast.
[7] M. Khoury. Dealing With the Evidence Dilemma in Genomics and Personalized Medicine , 2010, Clinical pharmacology and therapeutics.
[8] D. Matchar,et al. Challenges in and Principles for Conducting Systematic Reviews of Genetic Tests Used as Predictive Indicators -- Methods Guide for Medical Test Reviews , 2012 .